Adagene Inc.

About Adagene Inc.

Adagene is a biotechnology company focused on redefining the design and discovery of therapeutic antibodies. Their core technology leverages dynamic conformational diversity and protein motion to create a platform of unique, multi-purpose antibody technologies and a growing pipeline of leading assets with novel mechanisms of action (MOAs).

Products & Services

Dynamic Precision Library:A platform technology for antibody discovery and design.

NEObody:A technology for creating antibodies with novel epitopes.

SAFEbody:A technology focused on safety-enhanced antibody development.

Pipeline Programs:Includes specific antibody candidates like ADG126, ADG116, ADG206, ADG106, and preclinical programs.

Specialties

Therapeutic Antibodies Antibody Discovery and Design Dynamic Conformational Diversity Precision Engineering

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Equity Investment T: - FT: Equity Investment	A: 25000000 MR: - FA: up to $25 million FAN: 25000000	D: 2025-07-01 FD: 2025-07-01	1 investors

Equity Investment Latest

2025-07-01

$25.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

John Maraganore

Ph.D.

H

Heinz-Josef Lenz

Associate Director for Clinical Research and Co-leader of the Translational Science Program at the USC Norris Comprehensive Cancer Center, Professor of Medicine and Preventive Medicine

S

Stanley Frankel

Hematologist-Oncologist

D

David Gandara

Professor Emeritus and Senior Advisor of the Thoracic Oncology Program at University of California Davis Comprehensive Cancer Center (UCDCCC)

A

Aurélien Marabelle

Professor of Clinical Immunology

Y

Yiqin Gao

Professor

View 24 more team members with Pro

Unlock Full Team Directory

Recent News

Adagene Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised